博亚平台

当前位置: 博亚平台   师生风采

师生风采

黄志伟教授课题组揭示新冠肺炎重症和轻症患者的适应性免疫反应特征

来源:博亚平台 发布时间: 2021-09-04浏览次数: 15

HAGONGDABAOXUN(SHENGMING WEN/TU)8YUE14RI,HUANGZHIWEIJIAOSHOUKETIZUBOYAPINGTAIXINGUANFEIYANDEZUIXINYANJIUCHENGGUOYI《XINGUANFEIYANZHONGZHENGHEQINGZHENGHUANZHEDUIXINGUANBINGDUGANRANDESHIYINGXINGMIANYIFANYING》(Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals)WEITIZAIXIANFABIAOYU《XINHAOZHUANDAOYUBAXIANGZHILIAO》(Signal Transduction and Targeted Therapy)ZAZHI。

JIEZHI2020NIAN6YUE,SARS-CoV-2YINQIDEQUANQIUFANWEIDEXINGUANFEIYANYIQINGYIJINGYINGXIANGDAO800DUOWANREN,WEILEYANJIUCOVID-19HUANZHEZHENDUISARS-CoV-2GANRANDESHIYINGXINGMIANYIFANYINGJIZHIJIKANGFUHUANZHEDEMIANYIJIYIJIANLIQINGKUANG,GAITUANDUISHOUXIANYINGYONGDANXIBAOZHUANLUZUHEMIANYIZU(TCR/BCR)GAOTONGLIANGCEXUSHUJU,BINGJIEHEGONGNENGSHIYANDUIJIBINGYANZHONGCHENGDUBUTONGDECOVID-19HUANZHE(ZHONGZHENGHEQINGZHENG)WAIZHOUXUEZHONGSHIYINGXINGMIANYIXIBAODEXIANGYINGJIZHIJINXINGLEYANJIU,JIESHILET/BXIBAOZHENDUISARS-CoV-2GANRANERJINXINGDEMIANYIZUKUZHONGJIANTEZHENG,YIJICOVID-19YOUDAODEWAIZHOUXUELINBAXIBAOYAQUNZUCHENGBIANHUATEZHENG,FAXIANLETXIBAOMIANYIJIYIHEBXIBAOTIYEMIANYIFANYINGCHENGDUYUJIBINGYANZHONGCHENGDUCUNZAIYIDINGDEZHENGXIANGGUANXING,YIJIZHONGZHENGHEQINGZHENGHUANZHEBUTONGDEMIANYIXUEBIANHUATEZHENG(TUYI)。

博亚平台GAIYANJIUSHOUXIANFAXIAN,XIANGBIYUJIANKANGREN,COVID-19HUANZHEBIAODAXIBAODUXINGFENZI(RUGZMA、GZMB、PRF1、NKG7)DESHASHANGXINGTXIBAOYAQUN(CD8+XIAOYINGJIYIXIBAO(CD8+ TEM)、BIAODACD45RADECD8+ TEMXIBAOYAQUN(CD8+ TTE)HECD4+TTE)DEZHANBITIGAO,BIAOMINGZHEIXIESHASHANGXINGTXIBAODEZENGZHIYUCOVID-19YOUGUAN;TONGSHIFAXIANCOVID-19HUANZHEZHONGDENIANMOXIANGGUANHENGDINGTLINBAXIBAO(MAIT)XIANZHUJIANSHAO;ERSARS-CoV-2YOUDAODEGamma/delta TXIBAOXIAOHAOZAIHUIFUQIHUANZHEZHONGDEDAOYIDINGCHENGDUDEHUIFU,DANRENGWEIWANQUANHUIFUDAOZHENGCHANGSHUIPING,ZHEIXIEJIEGUOBIAOMINGCOVID-19HUANZHEDESHIYINGXINGMIANYIXITONGZAIKANGFUZAOQIBINGWEIDEDAOWANQUANHUIFU。

博亚平台WEILESHIBIEHUIFUQICOVID-19HUANZHEZHONGSARS-CoV-2TEYIXINGTXIBAOYAQUN,TUANDUISHOUXIANTONGGUOscRNA-seqHEscTCR-seqYANJIUBUTONGTXIBAOYAQUNDEKELONGKUOZENGQINGKUANG,FAXIANDUISARS-CoV-2XIANGYINGDEZHUYAOTXIBAOYAQUNBAOKUOCD8+ TEM、CD8+ TTEHECD4+TTE。WEILEYANJIUZHEIXIEKELONGKUOZENGDETXIBAOYAQUNSHIFOUBAXIANGXINGUANBINGDU,YONGLAIZIXINGUANBINGDUDE276TIAOQIANZAIDETXIBAOKANGYUANBIAOWEIDUOTAICIJIQING、ZHONGZHENGHUANZHEDETXIBAO,BINGJIANCEQIFANYINGHUOXING,FAXIANKANGFUQIDECOVID-19HUANZHETINEICUNZAIBAXIANGSDANBAIDENGXINGUANBINGDUDANBAIDETEYIXINGJIYITXIBAO,QIEFAXIANLAIZIZHONGZHENGHUANZHEDEYANGBENBIAOXIANCHUGENGQIANGLIEDETEYIXINGTXIBAOFANYING,BIAOMINGXIANGJIAOYUQINGZHENGHUANZHE,ZHONGZHENGHUANZHEDUIYUSARS-CoV-2JUYOUGENGQIANGDEJIYITXIBAOFANYINGXING。

ZAIBXIBAOMIANYIFANYINGFANGMIAN,TONGGUOZHENGHEBXIBAOZHUANLUZUHEBCRMIANYIZUCEXUSHUJU,FAXIANZAIZHONGZHENGHUANZHEZHONGJUYOUGENGMINGXIANDEBCRKELONGKUOZENG,XIANGBIYUZHENGCHANGRENHEQINGZHENGHUANZHEJIANGXIBAOZHANBIGENGGAO,BINGQIEYOUBXIBAOJIEDAODEMIANYITONGLUHEBUTIJIHUOTONGLUFASHENGSHANGDIAO,ZHEIXIEJIEGUOSHUOMINGGENGQIANGLIEDETIYEMIANYIFANYINGSHIZHONGZHENGHUANZHEDEDIANXINGTEDIAN。

博亚平台JINYIBUPINGGUZAOQIKANGFUHUANZHESHIYINGXINGMIANYIXITONGDEHUIFUQINGKUANG,FAXIANZAISUOYOUKANGFUHUANZHEDEDABUFENT/BXIBAOZHONGWEIJIANCEDAOCUYANXIBAOYINZIDEMINGXIANBIAODA,BIAOMINGZAICOVID-19HUANZHEDEKANGFUZAOQICUYANXIBAOYINZIKENENGYIJINGHUIFUDAOZHENGCHANGSHUIPING。ZHIDEZHUYIDESHI,YOUSIFENLIEYUANHUOHUADANBAIJIMEI(MAPK)TONGLU(FOS、JUN、JUNBHEDUSP1)DEBIAODAZAISUOYOUCOVID-19KANGFUHUANZHEZHONGJUNSHOUDAOYIZHI,ZHEIYEYUZHIQIANDEBAODAOFAXIANYIZHI。

CIWAI,BENYANJIUHAIFAXIANLEBUTONGCOVID-19HUANZHEDEKANGBINGDUFANYINGCUNZAIHENDADEYIZHIXING,TONGSHIYETISHILEBUTONGGETICUNZAIBUTONGDEKANGBINGDUFANYINGJIZHIDEKENENGXING,JIHOUXUGENGDAGUIMODEDUILIEYANJIUTICHULEGENGDUODEKENENGXING。BIRU,YOUHENDUOYANJIUYIBIAOMINGIXINGHEⅢXINGGANRAOSU(IFN)XINHAOTONGLUZAISARS-CoV-2HUOSARS-CoVGANRANZHONGFAHUIZHONGYAOZUOYONG。ERZAIBENYANJIUZHONG,JINZAI1LIWEIZHONGZHENGGANRANBINGLIHE1LIQINGDUGANRANBINGLIZHONGJIANCEDAOTXIBAOIFNYINGDA,ZHEIZHONGIFNYINGDADEYIZHIXINGBIAOMINGZAISARS-CoV-2GANRANGUOCHENGZHONGTXIBAOIFNTONGLUDEJIHUOJIQIYULINCHUANGBIAOXINGHEKANGBINGDUMIANYIFANYINGZHIJIANDEGUANXIRENGYOUDAIJINYIBUCHANMING。ZAIYILINIANQINGDEZHONGZHENGBINGREN(44SUI)ZHONGHAIFAXIANLEIGHV4-34 BCRKELONGDEGAODUKUOZENG,ERZHEIZHONGKELONGXINGHENSHAOCHUXIANZAIJIANKANGGETIDEIgGJIYIXINGBXIBAOZHONG,QIEYOUYANJIUBIAOMINGQIYUYIXIEZISHENMIANYIXINGJIBINGXIANGGUAN,TISHIYOUBINGDUGANRANYOUFADEZISHENMIANYIFANYINGYEKENENGSHICHANSHENGZHONGZHENGBIAOXINGDEYIGEKENENGYUANYIN。

博亚平台ZHEIXIANGYANJIUDUIYULIJIEZHONGZHENGHEQINGZHENGHUANZHEDEFABINGHEKANGFUJIZHI,YIJISHEJIFANGZHISARS-CoV-2GANRANDEYIMIAOHEZHILIAOYAOWUJUYOUZHONGYAOYIYI。

博亚平台HUANGZHIWEIJIAOSHOUWEIGAIYANJIULUNWENDETONGXUNZUOZHE,SHENGMINGXUEYUANFUJIAOSHOUZHANGFAN、SHUOSHIYANJIUSHENGGANRUI、BOSHIYANJIUSHENGZHENZIQI、HEILONGJIANGSHENGYIYUANGANRANKEZHURENHUXIAOLIWEIGAIYANJIULUNWENDEBINGLIEDIYIZUOZHE,BOSHIYANJIUSHENGLIXIANGHEZHOUFENGXIADUIBENYANJIUZUOCHULEZHONGYAOGONGXIAN。BENYANJIUSHOUDAOGUOJIAZIRANKEXUEJIJINWEI、HAGONGDAQINGNIANKEXUEJIAGONGZUOSHI、HAGONGDAXINXINGGUANZHUANGBINGDUFEIYANYIQINGYINGJIKEYANGONGGUANXIANGMUDENGJIJINDEZIZHU。

TUYI COVID-19HUANZHEZHENDUISARS-CoV-2GANRANDESHIYINGXINGMIANYIFANYINGJIMIANYIJIYIJIANLIQINGKUANG

WENZHANGLIANJIE:

YUANZIHAERBINGONGYEDAXUE,ZUIHOUGENGXINSHIJIAN 2021-09-06

博亚平台 泛亚体育 泛亚体育 泛亚体育 博亚平台 博电竞 泛亚体育